Weight loss jabs like Ozempic 'trigger panic attacks' and worsen anxiety, experts discover
Thousands of users have now reported experiencing severe anxiety and 'meltdowns' which they believe are linked to using ...
Why Specialty Pharmacy May Be Walgreens Most Desirable Asset To Buyers
The specialty pharmacy business may be the most attractive part of Walgreens as rumors swirl the company will be taken over ...
Big Food Is Fighting Back Against Big Pharma In War Over People’s Weight
The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...
health.economictimes.indiatimes5d
Gerresheimer slashes revenue guidance for 2025 in half
Gerresheimer: The company now expects organic revenue growth in the range of 3 per cent to 5 per cent in 2025, down from the ...
Food Dive4d
Why food makers aren’t afraid of GLP-1 drugs
Companies such as PepsiCo and Mondelēz haven’t seen an impact on business, while Healthy Choice maker Conagra sees the ...
pharmaphorum4d
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 world
Ozempic, along with its sister drug Wegovy, belongs to a new class of ... with combinations of letters and numbers printed on the packaging, which are then used to track the product in a given ...
Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Reuters5d
Medtech News | Today's Latest Stories | Reuters
German packaging and medical equipment maker Gerresheimer , which makes pens used to inject weight loss drugs such as Novo Nordisk's Wegovy, halved its revenue guidance for 2025 on Wednesday.